fbpx
1-888-310-4540 (main) / 1-888-707-6150 (support) info@spkaa.com
Select Page

Design Output: A Review of 21 C.F.R. §820.30(d) and FDA Warning Letter Trends

Introduction

Does your company properly manage Design Outputs?  The FDA routinely examines this area as part of an audit process.   In this article we review what it means to have your design outputs in order as well as present some recent warning letter examples.

We invite you to download our paper on this topic.

Learn more about IT FDA requirements and compliance training best practices to help your business gain the competitive market advantage.

Latest White Papers

Excellence in Automotive Software Engineering eBook

Excellence in Automotive Software Engineering eBook

ALM tooling, when implemented correctly, can support automotive software engineering, Agile transformation journeys and linking requirements to business strategy, encouraging collaboration. Additionally, it can be helpful for providing an overview of QA and testing...

Related Resources

Top Takeaways from SolidWorks 3DEXPERIENCE World 2024

Top Takeaways from SolidWorks 3DEXPERIENCE World 2024

The 3DExperience (3DX) World 2024 displayed the convergence of innovative technologies and creative ideas in design and engineering. Hosted by Dassault Systèmes, it is an epicenter for SolidWorks users, third-party app suppliers, gold partners, and major workstation...

Excellence in Automotive Software Engineering eBook

Excellence in Automotive Software Engineering eBook

ALM tooling, when implemented correctly, can support automotive software engineering, Agile transformation journeys and linking requirements to business strategy, encouraging collaboration. Additionally, it can be helpful for providing an overview of QA and testing...

Shifting from FDA 21 CFR Part 820 to ISO 13485

Shifting from FDA 21 CFR Part 820 to ISO 13485

In this Vlog, Chris McHale, Co-founder, and CEO of SPK and Associates is joined by Carlos Almeida, Vice President of Engineering. Together, they’re discussing FDA compliance and the recent shifts impacting medical device companies. Topics for discussion include...